Literature DB >> 16177006

Acute kidney injury, mortality, length of stay, and costs in hospitalized patients.

Glenn M Chertow1, Elisabeth Burdick, Melissa Honour, Joseph V Bonventre, David W Bates.   

Abstract

The marginal effects of acute kidney injury on in-hospital mortality, length of stay (LOS), and costs have not been well described. A consecutive sample of 19,982 adults who were admitted to an urban academic medical center, including 9210 who had two or more serum creatinine (SCr) determinations, was evaluated. The presence and degree of acute kidney injury were assessed using absolute and relative increases from baseline to peak SCr concentration during hospitalization. Large increases in SCr concentration were relatively rare (e.g., >or=2.0 mg/dl in 105 [1%] patients), whereas more modest increases in SCr were common (e.g., >or=0.5 mg/dl in 1237 [13%] patients). Modest changes in SCr were significantly associated with mortality, LOS, and costs, even after adjustment for age, gender, admission International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis, severity of illness (diagnosis-related group weight), and chronic kidney disease. For example, an increase in SCr >or=0.5 mg/dl was associated with a 6.5-fold (95% confidence interval 5.0 to 8.5) increase in the odds of death, a 3.5-d increase in LOS, and nearly 7500 dollars in excess hospital costs. Acute kidney injury is associated with significantly increased mortality, LOS, and costs across a broad spectrum of conditions. Moreover, outcomes are related directly to the severity of acute kidney injury, whether characterized by nominal or percentage changes in serum creatinine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177006     DOI: 10.1681/ASN.2004090740

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  1102 in total

1.  Studies on the mechanism of the changes in serum and liver gamma-glutamyl transpeptidase activity. II. Experimental hexachlorobenzene porphyria in rabbits.

Authors:  E Ivanov; L Krustev; D Adjarov; K Chernev; I Apostolov; P Dimitrov; E Drenska; M Stefanova; V Pramatarova
Journal:  Enzyme       Date:  1976

Review 2.  Information Technology and Acute Kidney Injury: Alerts, Alarms, Bells, and Whistles.

Authors:  F Perry Wilson
Journal:  Adv Chronic Kidney Dis       Date:  2017-07       Impact factor: 3.620

3.  BPI Fold-Containing Family A Member 2/Parotid Secretory Protein Is an Early Biomarker of AKI.

Authors:  Satya K Kota; Elizabeth Pernicone; David E Leaf; Isaac E Stillman; Sushrut S Waikar; Savithri Balasubramanian Kota
Journal:  J Am Soc Nephrol       Date:  2017-08-03       Impact factor: 10.121

4.  Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury.

Authors:  Frank Dieterle; Elias Perentes; André Cordier; Daniel R Roth; Pablo Verdes; Olivier Grenet; Serafino Pantano; Pierre Moulin; Daniel Wahl; Andreas Mahl; Peter End; Frank Staedtler; François Legay; Kevin Carl; David Laurie; Salah-Dine Chibout; Jacky Vonderscher; Gérard Maurer
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

5.  Next-generation biomarkers for detecting kidney toxicity.

Authors:  Joseph V Bonventre; Vishal S Vaidya; Robert Schmouder; Peter Feig; Frank Dieterle
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

6.  Clinical Evidence of Acute Mesoamerican Nephropathy.

Authors:  Rebecca S B Fischer; Sreedhar Mandayam; Denis Chavarria; Chandan Vangala; Melissa S Nolan; Linda L Garcia; Lesbia Palma; Felix Garcia; Ramón García-Trabanino; Kristy O Murray
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

7.  Characteristics and Outcomes of Patients Discharged Home from an Emergency Department with AKI.

Authors:  Rey R Acedillo; Ron Wald; Eric McArthur; Danielle Marie Nash; Samuel A Silver; Matthew T James; Michael J Schull; Edward D Siew; Michael E Matheny; Andrew A House; Amit X Garg
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-20       Impact factor: 8.237

Review 8.  The Japanese clinical practice guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  Clin Exp Nephrol       Date:  2018-10       Impact factor: 2.801

9.  Extendin-4 protects kidney from acute ischemia-reperfusion injury through upregulation of NRF2 signaling.

Authors:  Yen-Yi Zhen; Chih-Chao Yang; Chi-Chih Hung; Chia-Chang Lee; Chen-Chang Lee; Chien-Hsing Wu; Yen-Ta Chen; Wei-Yu Chen; Kuan-Hung Chen; Hon-Kan Yip; Sheung-Fat Ko
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 10.  Fluid overload in AKI: epiphenomenon or putative effect on mortality?

Authors:  Brad W Butcher; Kathleen D Liu
Journal:  Curr Opin Crit Care       Date:  2012-12       Impact factor: 3.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.